分组1 - DarioHealth Corp. reported a quarterly loss of $0.8 per share, which was better than the Zacks Consensus Estimate of a loss of $1.57, representing an earnings surprise of +48.88% [1] - The company posted revenues of $5.23 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.17%, but down from $7.6 million year-over-year [2] - DarioHealth shares have declined approximately 21.5% since the beginning of the year, contrasting with the S&P 500's decline of 3.2% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.67 on revenues of $5.1 million, and for the current fiscal year, it is -$3.43 on revenues of $26.8 million [7] - The Zacks Industry Rank for Medical - Instruments is in the top 36% of over 250 Zacks industries, indicating that the industry is performing relatively well [8]
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates